Global Neisseria Gonorrhoeae Infections Treatment Market Data Survey Report 2025
- HEY2872291
- 66 Pages
- January 2018
- Medical Devices
The global Neisseria Gonorrhoeae Infections Treatment market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
GlaxoSmithKline Plc
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd
Major applications as follows:
Clinic
Hospital
Others
Major Type as follows:
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Allergan Plc
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 BioDiem Ltd
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Biolytics Pharma
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Debiopharm International SA
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 F. Hoffmann-La Roche Ltd.
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GlaxoSmithKline Plc
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GlaxoSmithKline Plc
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Paratek Pharmaceuticals, Inc.
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Recce Pty Ltd
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Redx Pharma Plc
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Sarepta Therapeutics, Inc.
3.12 Sumitomo Dainippon Pharma Co., Ltd
4 Major Application
4.1 Clinic
4.1.1 Overview
4.1.2 Clinic Market Size and Forecast
4.2 Hospital
4.2.1 Overview
4.2.2 Hospital Market Size and Forecast
4.3 Others
4.3.1 Overview
4.3.2 Others Market Size and Forecast
5 Market by Type
5.1 Cribrostatin-6
5.1.1 Overview
5.1.2 Cribrostatin-6 Market Size and Forecast
5.2 Dalbavancin
5.2.1 Overview
5.2.2 Dalbavancin Market Size and Forecast
5.3 Debio-1453
5.3.1 Overview
5.3.2 Debio-1453 Market Size and Forecast
5.4 Gepotidacin Mesylate
5.4.1 Overview
5.4.2 Gepotidacin Mesylate Market Size and Forecast
5.5 Others
5.5.1 Overview
5.5.2 Others Market Size and Forecast
5.6 Others
5.6.1 Overview
5.6.2 Others Market Size and Forecast
6 Conclusion
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Allergan Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of BioDiem Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Biolytics Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Debiopharm International SA
Tab Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of Paratek Pharmaceuticals, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Recce Pty Ltd
Tab Sales Revenue, Volume, Price, Cost and Margin of Redx Pharma Plc
Tab Sales Revenue, Volume, Price, Cost and Margin of Sarepta Therapeutics, Inc.
Tab Sales Revenue, Volume, Price, Cost and Margin of Sumitomo Dainippon Pharma Co., Ltd
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
